EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC 4.0

Association Between Single Nucleotide Polymorphisms and Disease Susceptibility, Survival, and Acute Exacerbation in Idiopathic Pulmonary Fibrosis

Kazuya Tsubouchi iD, Toyoshi Yanagihara iD, Fumiaki Kiyomi, Yuzo Yamamoto, Masako Arimura-Omori, Naoki Hamada, Katsuyuki Ichiki, Shohei Takata, Hiroshi Ishii iD, Yasuhiko Kitasato, Masaki Okamoto iD, Satoru Kawakami und 7 weitere

Respirology · 2026

DOI: 10.1111/resp.70120 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Respirology, 2026. Verfasst von Kazuya Tsubouchi und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Polymorphism, Single Nucleotide, Genetic Predisposition to Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The Diffuse Lung Diseases Research Group from the Ministry of Health, Labor, and Welfare of Japan, Boehringer Ingelheim, The Ministry of Education, Culture, Sports, Science, and Technology of Japan for a broad-area, network-based project to drive clinical research at Kyushu Unive….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective Genetic polymorphisms have been associated with susceptibility to interstitial lung diseases including idiopathic pulmonary fibrosis (IPF). We have now examined the relation between single nucleotide polymorphisms (SNPs) and clinical course, including acute exacerbation (AE), in addition to disease susceptibility for IPF and unclassifiable idiopathic interstitial pneumonias (IIPs).

Methods

DNA samples were collected from 223 IPF patients and 160 unclassifiable IIP patients included in a prospective, multicentre observational study in Japan. Nonfibrotic control subjects ( n = 379) were selected from a previous study. Genotyping of TERT rs2736100, TERC rs1881984, MUC5B rs35705950, DSP rs2076295, and AKAP13 rs62025270 was conducted with commercial assays. The association between these SNPs and disease susceptibility, prognosis, or the cumulative incidence of AE was assessed.

Results

TERT rs2736100 and MUC5B rs35705950 were significantly associated with IPF risk, and DSP rs2076295 was linked to prognosis and the incidence of AE in IPF patients. TERT rs2736100 was significantly associated with prognosis in IPF patients and the incidence of AE in patients with unclassifiable IIPs. No individuals with the TT genotype of MUC5B rs35705950 were identified, and the proportion of those with the T allele was low (minor allele frequency of 0.005 in control subjects). In addition, no individuals with the minor allele ( A ) of AKAP13 rs62025270 were detected.

Conclusion

Consideration of genetic polymorphisms has the potential to facilitate prediction not only of prognosis but also of AE in individuals with IIPs, providing a foundation for the development of personalised management strategies based on genetic profiles. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Idiopathic Pulmonary FibrosisPolymorphism, Single NucleotideGenetic Predisposition to DiseaseHumansMaleFemaleAgedMucin-5BMiddle AgedProspective StudiesTelomerasePrognosisJapanA Kinase Anchor ProteinsDisease ProgressionGenotypeIdiopathic Interstitial PneumoniasCase-Control Studies

Stichwörter der Autor:innen

acute exacerbationdesmoplakinidiopathic pulmonary fibrosissingle nucleotide polymorphismstelomere

Substanzen

TERT protein, humanMucin-5BMUC5B protein, humanTelomeraseA Kinase Anchor Proteins

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Respiratory Medicine, Fukuoka University School of Medicine, Fukuoka, Japan.
  • Clinical Research Support Center Kyushu, Fukuoka, Japan.
  • Department of Respiratory Medicine, Japan Community Health Care Organization Kyushu Hospital, Kitakyushu, Japan.
  • Kirigaoka Tsuda Hospital, Kitakyushu, Japan.
  • Department of Respiratory Diseases, NHO Fukuokahigashi Medical Center, Koga, Japan.

ORCID-Profile: Kazuya Tsubouchi, Toyoshi Yanagihara, Hiroshi Ishii, Masaki Okamoto, Kazuhiro Yatera, Isamu Okamoto

Förderung

  • The Diffuse Lung Diseases Research Group from the Ministry of Health, Labor, and Welfare of Japan
  • Boehringer Ingelheim
  • The Ministry of Education, Culture, Sports, Science, and Technology of Japan for a broad-area, network-based project to drive clinical research at Kyushu Unive…

Zitieren

APA

Tsubouchi, K., Yanagihara, T., Kiyomi, F., Yamamoto, Y., Arimura-Omori, M., Hamada, N., Ichiki, K., Takata, S., Ishii, H., Kitasato, Y., Okamoto, M., Kawakami, S., Yatera, K., Kawasaki, M., Fujita, M., Tokunaga, S., Kiyohara, C., Nakanishi, Y., & Okamoto, I. (2026). Association Between Single Nucleotide Polymorphisms and Disease Susceptibility, Survival, and Acute Exacerbation in Idiopathic Pulmonary Fibrosis. Respirology. https://doi.org/10.1111/resp.70120

Vancouver

Tsubouchi K, Yanagihara T, Kiyomi F, Yamamoto Y, Arimura-Omori M, Hamada N, et al. Association Between Single Nucleotide Polymorphisms and Disease Susceptibility, Survival, and Acute Exacerbation in Idiopathic Pulmonary Fibrosis. Respirology. 2026. doi:10.1111/resp.70120

BibTeX
@article{Tsubouchi2026,
  author = {Tsubouchi, Kazuya and Yanagihara, Toyoshi and Kiyomi, Fumiaki and Yamamoto, Yuzo and Arimura-Omori, Masako and Hamada, Naoki and Ichiki, Katsuyuki and Takata, Shohei and Ishii, Hiroshi and Kitasato, Yasuhiko and Okamoto, Masaki and Kawakami, Satoru and Yatera, Kazuhiro and Kawasaki, Masayuki and Fujita, Masaki and Tokunaga, Shoji and Kiyohara, Chikako and Nakanishi, Yoichi and Okamoto, Isamu},
  title = {Association Between Single Nucleotide Polymorphisms and Disease Susceptibility, Survival, and Acute Exacerbation in Idiopathic Pulmonary Fibrosis},
  journal = {Respirology},
  year = {2026},
  doi = {10.1111/resp.70120}
}
Kostenlos starten →